☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
companion diagnostic
Chugai Receives MHLW's Approval for the Expanded Use of FoundationOne CDx as a Companion Diagnostic of Rozlytrek (entrectinib)
December 27, 2019
Myriad to File sPMA to the US FDA of BRACAnalysis CDx as a Companion Diagnostic for Lynparza (olaparib) to Treat Metastatic Castra...
August 8, 2019
Myriad Expands its Companion Diagnostic Collaboration with AstraZeneca and Merck
April 5, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.